Periodic Reporting for period 1 - Bronchomycn (First in class epithelial Barrier-enhancing medicine for respiratory diseases)

EpiEndo is a biotech company that leads innovative compound design and preclinical research for drug development. We have established an in-house platform focusing on the discovery and development of novel compounds that restore the physiological integrity of epithelial...